Thrombin-activatable fibrinolysis inhibitor (TAFI) levels and its polymorphism rs3742264 are associated with dyslipidemia in a cohort of Brazilian subjects.

Izabela R Santos,Ana P Fernandes,Maria G Carvalho,Marinez O Sousa,Cláudia N Ferreira,Karina B Gomes

Clinica Chimica Acta（2014）

引用 4|浏览2

暂无评分

摘要

•TAFI levels are independently associated to dyslipidemia.•The rs1926447, rs3742264 and rs940 polymorphisms showed association with TAFI levels.•The rs3742264 polymorphism was associated with dyslipidemia in males.

查看译文

关键词

Dyslipidemia,Fibrinolysis,Polymorphisms,Risk factor,TAFI

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要